National Cancer Institute (NCI) state of the science: Targeted radiosensitizers in colorectal cancer

Author:

George Thomas J.1ORCID,Franke Aaron J.1ORCID,Chakravarthy A. Bapsi2ORCID,Das Prajnan3,Dasari Arvind4ORCID,El‐Rayes Bassel F.5ORCID,Hong Theodore S.6,Kinsella Timothy J.7,Landry Jerome C.5,Lee James J.8,Monjazeb Arta M.9,Jacobs Samuel A.10,Raben David11,Rahma Osama E.12,Williams Terence M.13,Wu Christina5ORCID,Coleman C. Norman14,Vikram Bhadrasain14ORCID,Ahmed Mansoor M.14

Affiliation:

1. Division of Hematology and Oncology, Department of Medicine University of Florida Gainesville Florida

2. Department of Radiation Oncology, Vanderbilt‐Ingram Cancer Center Vanderbilt University Medical Center Nashville Tennessee

3. Department of Radiation Oncology The University of Texas MD Anderson Cancer Center Houston Texas

4. Department of Gastrointestinal Medical Oncology The University of Texas MD Anderson Cancer Center Houston Texas

5. Department of Hematology and Oncology Winship Cancer Institute, Emory University Atlanta Georgia

6. Department of Radiation Oncology Massachusetts General Hospital, Harvard Boston Massachusetts

7. Department of Radiation Oncology Rhode Island Hospital‐Brown University Alpert Medical School Providence Rhode Island

8. Division of Hematology‐Oncology, Department of Medicine University of Pittsburgh Medical Center, Hillman Cancer Center, University of Pittsburgh School of Medicine Pittsburgh Pennsylvania

9. Division of Radiation Oncology University of California Davis Comprehensive Cancer Center Sacramento California

10. National Adjuvant Surgical and Bowel Project Foundation/NRG Oncology Pittsburg Pennsylvania

11. Department of Radiation Oncology University of Colorado Denver School of Medicine Aurora Colorado

12. Center for Immuno‐Oncology, Department of Medical Oncology Dana Farber Cancer Institute and Harvard Medical School Boston Massachusetts

13. Department of Radiation Oncology The Ohio State University Columbus Ohio

14. Clinical Radiation Oncology Branch, Radiation Research Program National Cancer Institute, National Institutes of Health Bethesda Maryland

Publisher

Wiley

Subject

Cancer Research,Oncology

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3